Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-08-28

Clinical Trial Update: RNS® System Pivotal Study [Phase 3]

View source ↗

Summary

NeuroPace's RNS System completed a pivotal Phase 3 trial for epilepsy. Results from the study were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RNS System (responsive neurostimulation device)

Snippet

Sponsor: NeuroPace | Conditions: Epilepsy | Phase 3 | Status: COMPLETED | Results posted: 2013-08-28